Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
, 46 (2), 226-7

Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn's Disease: The CHARM Trial. Colombel JF, Sandborn WJ, Rutgeerts P Et Al. Gastroenterology 2007;132:52-65

Affiliations
Comment

Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn's Disease: The CHARM Trial. Colombel JF, Sandborn WJ, Rutgeerts P Et Al. Gastroenterology 2007;132:52-65

Nadeem Z Jilani et al. J Pediatr Gastroenterol Nutr.

Comment on

Similar articles

See all similar articles

Cited by 3 PubMed Central articles

LinkOut - more resources

Feedback